Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/123718
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Efficacy of combined CDK9/13ET inhibition in preclinical models of MLL-rearranged acute leukemia |
Author: | McCalmont, H. Li, K.L. Jones, L. Toubia, J. Bray, S.C. Casolari, D.A. Mayoh, C. Samaraweera, S.E. Lewis, I.D. Prinjha, R.K. Smithers, N. Wang, S. Lock, R.B. D'Andrea, R.J. |
Citation: | Blood Advances, 2020; 4(2):296-300 |
Publisher: | American Society of Hematology |
Issue Date: | 2020 |
ISSN: | 2473-9529 2473-9537 |
Statement of Responsibility: | Hannah McCalmont, Ka Leung Li, Luke Jones, John Toubia, Sarah C. Bray, Debora A. Casolari ... at al. |
Abstract: | Abstract not available |
Keywords: | Lymphoid neoplasia; myeloid neoplasia; stimulus report |
Rights: | © 2020 by The American Society of Hematology |
DOI: | 10.1182/bloodadvances.2019000586 |
Grant ID: | http://purl.org/au-research/grants/nhmrc/1059804 http://purl.org/au-research/grants/nhmrc/1157871 http://purl.org/au-research/grants/nhmrc/1091261 |
Published version: | http://dx.doi.org/10.1182/bloodadvances.2019000586 |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.